OBJECTIVE: Mulago and Mbarara hospitals are large tertiary hospitals in Uganda with a high HIV/AIDS burden. Until recently, HIV testing was available only upon request and payment. From November 2004, routine free HIV testing and counselling has been offered to improve testing coverage and the clinical management of patients. All patients in participating units who had not previously tested HIV-positive were offered HIV testing. Family members of patients seen at the hospitals were also offered testing. METHODS: Data collected at the 25 participating wards and clinics between 1 November 2004 and 28 February 2006 were analysed to determine the uptake rate of testing and the HIV seroprevalence among patients and their family members. FINDINGS: Of the 51,642 patients offered HIV testing, 50,649 (98%) accepted. In those who had not previously tested HIV-positive, the overall HIV prevalence was 25%, with 81% being tested for the first time. The highest prevalence was found in medical inpatients (35%) and the lowest, in surgical inpatients (12%). The prevalence of HIV was 28% in the 39,037 patients who had never been tested before and 9% in those who had previously tested negative. Of the 10,439 family members offered testing, 9720 (93%) accepted. The prevalence in family members was 20%. Among 1213 couples tested, 224 (19%) had a discordant HIV status. CONCLUSION: In two large Ugandan hospitals, routine HIV testing and counselling was highly acceptable and identified many previously undiagnosed HIV infections and HIV-discordant partnerships among patients and their family members.
OBJECTIVE: Mulago and Mbarara hospitals are large tertiary hospitals in Uganda with a high HIV/AIDS burden. Until recently, HIV testing was available only upon request and payment. From November 2004, routine free HIV testing and counselling has been offered to improve testing coverage and the clinical management of patients. All patients in participating units who had not previously tested HIV-positive were offered HIV testing. Family members of patients seen at the hospitals were also offered testing. METHODS: Data collected at the 25 participating wards and clinics between 1 November 2004 and 28 February 2006 were analysed to determine the uptake rate of testing and the HIV seroprevalence among patients and their family members. FINDINGS: Of the 51,642 patients offered HIV testing, 50,649 (98%) accepted. In those who had not previously tested HIV-positive, the overall HIV prevalence was 25%, with 81% being tested for the first time. The highest prevalence was found in medical inpatients (35%) and the lowest, in surgical inpatients (12%). The prevalence of HIV was 28% in the 39,037 patients who had never been tested before and 9% in those who had previously tested negative. Of the 10,439 family members offered testing, 9720 (93%) accepted. The prevalence in family members was 20%. Among 1213 couples tested, 224 (19%) had a discordant HIV status. CONCLUSION: In two large Ugandan hospitals, routine HIV testing and counselling was highly acceptable and identified many previously undiagnosed HIV infections and HIV-discordant partnerships among patients and their family members.
Authors: I De Zoysa; K A Phillips; M C Kamenga; K R O'Reilly; M D Sweat; R A White; O A Grinstead; T J Coates Journal: AIDS Date: 1995 Impact factor: 4.177
Authors: Andrew D Forsyth; Thomas J Coates; Olga A Grinstead; Gloria Sangiwa; Donald Balmer; Munkolenkole C Kamenga; Steven E Gregorich Journal: Am J Public Health Date: 2002-11 Impact factor: 9.308
Authors: Curt G Beckwith; Timothy P Flanigan; Carlos del Rio; Emma Simmons; Edward J Wing; Charles C J Carpenter; John G Bartlett Journal: Clin Infect Dis Date: 2005-02-28 Impact factor: 9.079
Authors: Jonathan Mermin; John Lule; John Paul Ekwaru; Samuel Malamba; Robert Downing; Ray Ransom; Frank Kaharuza; David Culver; Francis Kizito; Rebecca Bunnell; Aminah Kigozi; Damalie Nakanjako; Winnie Wafula; Robert Quick Journal: Lancet Date: 2004 Oct 16-22 Impact factor: 79.321
Authors: Rebecca V Liddicoat; Nicholas J Horton; Renata Urban; Elizabeth Maier; Demian Christiansen; Jeffrey H Samet Journal: J Gen Intern Med Date: 2004-04 Impact factor: 5.128
Authors: Robert A Anderson; Alla Aroutcheva; Kenneth A Feathergill; Amillia B Anderson Journal: Probiotics Antimicrob Proteins Date: 2009-03-04 Impact factor: 4.609
Authors: David M Silvestri; Kayvon Modjarrad; Meridith L Blevins; Elizabeth Halale; Sten H Vermund; Jeffry P McKinzie Journal: J Acquir Immune Defic Syndr Date: 2011-01-01 Impact factor: 3.731
Authors: Ronald J Lubelchek; Anna L Hotton; Daniel Taussig; David Amarathithada; Marisol Gonzalez Journal: J Acquir Immune Defic Syndr Date: 2013-11-01 Impact factor: 3.731
Authors: Susan M Kiene; Moses Bateganya; Rhoda Wanyenze; Haruna Lule; Harriet Nantaba; Michael D Stein Journal: AIDS Patient Care STDS Date: 2010-02 Impact factor: 5.078
Authors: Eric D McCollum; Geoffrey A Preidis; Mark M Kabue; Emmanuel B M Singogo; Charles Mwansambo; Peter N Kazembe; Mark W Kline Journal: PLoS One Date: 2010-03-10 Impact factor: 3.240
Authors: Ibrahim Sendagire; Imke Schreuder; Mesach Mubiru; Maarten Schim van der Loeff; Frank Cobelens; Joseph Konde-Lule Journal: BMC Public Health Date: 2010-03-31 Impact factor: 3.295
Authors: Stephanie M Topp; Julien M Chipukuma; Mark Giganti; Linah K Mwango; Like M Chiko; Bushimbwa Tambatamba-Chapula; Chibesa S Wamulume; Stewart Reid Journal: PLoS One Date: 2010-07-13 Impact factor: 3.240
Authors: Lars T Fadnes; Ingunn Marie S Engebretsen; Karen Marie Moland; Jolly Nankunda; James K Tumwine; Thorkild Tylleskär Journal: BMC Health Serv Res Date: 2010-09-06 Impact factor: 2.655